Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Organovo Holdings, Inc. (ONVO)  
$0.99 0.04 (4.1%) as of 4:30 Tue 5/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 6,530,000
Market Cap: 6.46(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.9 - $1.94
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Organovo Holdings is a biotechnology company that focuses on building 3D tissues that recapitulate main aspects of human disease. Co. uses these models to identify gene targets responsible for driving the disease and intend to initiate drug discovery programs around these validated targets. Co.'s NovoGen Bioprinters® are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells. Co.'s NovoGen Bioprinters® can also dispense pure hydrogel formulations, provided the physical properties of the hydrogel are compatible with the dispensing parameters. Co.'s NovoGen Bioprinters® also serve as components of its tissue prototyping and manufacturing platform.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 19,607 19,607 19,607
Total Sell Value $0 $31,750 $31,750 $31,750
Total People Sold 0 1 1 1
Total Sell Transactions 0 1 1 1
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 151
  Page 6 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bush Jennifer General Counsel & Secretary   •       –      –    2016-07-11 4 A $0.00 $0 D/D 50,000 50,000     -
   Gallant Paul General Manager   •       –      –    2016-07-11 4 A $0.00 $0 D/D 47,500 47,500     -
   David Eric CSO & EVP Pre-Clinical Dev   •       –      –    2016-07-11 4 A $0.00 $0 D/D 50,000 726,306     -
   David Eric CSO & EVP Pre-Clinical Dev   •       –      –    2016-03-30 5 GD $0.00 $0 D/D 5,000 676,306     -
   Murphy Keith Chairman, CEO and President   •       •      –    2016-02-16 4 D $2.04 $50,368 D/D (24,690) 5,919,638     -
   Baltera Robert Jr. Director   –       •      –    2015-09-21 4 AS $4.03 $24,193 D/D (6,000) 138,506     -
   Michaels Barry D Chief Financial Officer   •       –      –    2015-08-31 5 GD $0.00 $0 D/D 86,808 0     -
   Michaels Barry D Chief Financial Officer   •       –      –    2015-08-24 4 D $2.32 $233,605 D/D (100,692) 86,808     -
   Glover James T Director   –       •      –    2015-08-13 4 B $2.80 $28,000 D/D 10,000 10,000 2.39     -
   Murphy Keith Chairman, CEO and President   •       •      –    2015-08-12 4 B $2.56 $51,188 D/D 20,000 5,944,328 2.81     -
   Presnell Sharon Collins EVP, Research & Dev & CTO   •       –      –    2015-03-12 4 OE $0.08 $4,000 D/D 50,000 74,064     -
   Murphy Keith Chairman, CEO and President   •       •      –    2015-02-13 4 D $6.34 $177,571 D/D (28,008) 5,961,328     -
   David Eric Chief Strategy Officer   •       –      –    2014-12-30 4 AS $7.56 $123,243 D/D (16,300) 681,306     -
   Michaels Barry D Chief Financial Officer   •       –      –    2014-12-30 4 AS $7.50 $78,771 I/I (10,500) 285,646     -
   David Eric Chief Strategy Officer   •       –      –    2014-12-29 4 AS $7.50 $27,754 D/D (3,700) 697,706     -
   Michaels Barry D Chief Financial Officer   •       –      –    2014-12-29 4 AS $7.50 $33,750 I/I (4,500) 296,146     -
   Presnell Sharon Collins EVP, Research & Dev & CTO   •       –      –    2014-10-06 4 AS $6.11 $305,475 D/D (50,000) 24,064     -
   Murphy Keith Chairman, CEO and President   •       •      –    2014-10-01 5 GD $0.00 $0 D/D 6,000 5,924,328     -
   David Eric Chief Strategy Officer   •       –      –    2014-09-12 4 AS $7.30 $218,973 D/D (30,000) 701,306     -
   Michaels Barry D Chief Financial Officer   •       –      –    2014-09-11 4 GD $0.00 $0 D/D 300,646 187,500     -
   Presnell Sharon Collins EVP, Research & Dev & CTO   •       –      –    2014-09-10 5 GD $0.00 $0 D/D 5,000 69,064     -
   Michaels Barry D Chief Financial Officer   •       –      –    2014-08-26 4 OE $2.25 $50,499 D/D 18,474 488,146     -
   Michaels Barry D Chief Financial Officer   •       –      –    2014-08-25 4 D $7.94 $815,914 D/D (102,760) 469,672     -
   Murphy Keith Chairman, CEO and President   •       •      –    2014-07-09 5 GD $0.00 $0 D/D 31,000 5,930,328     -
   Baltera Robert Jr. Director   –       •      –    2014-06-06 4 OE $1.00 $3,000 D/D 3,000 144,506     -
  151 Records found
  1  2  3  4  5  6  7   
  Page 6 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us